Prelude Therapeutics

Founded in 2016 and headquartered in Newark, Delaware, Prelude Therapeutics Incorporated operates as a biopharmaceutical company. The Company develops and designs a pipeline of novel, orally bioavailable, and small molecule therapies that target key drivers of cancer cell growth.